- Stocks
- Healthcare
- NASDAQ: NTRA

Price (delayed)

$44.97

Market cap

$5.15B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$4.82

Enterprise value

$5.21B

Naterais a pioneer and global leader in cell-free DNA testing from a simple blood draw. The mission of the company is to change the management of disease worldwide with a

NTRA's revenue is up by 29% year-on-year and by 7% since the previous quarter

The EPS has increased by 21% YoY and by 10% from the previous quarter

NTRA's equity is up by 34% year-on-year but it is down by 8% since the previous quarter

The company's debt rose by 9% YoY

The gross margin has declined by 8% year-on-year

What are the main financial stats of NTRA

Market
Valuations
Earnings

Shares outstanding

114.6M

Market cap

$5.15B

Enterprise value

$5.21B

Price to earnings (P/E)

N/A

Price to book (P/B)

8.62

Price to sales (P/S)

5.49

EV/EBIT

N/A

EV/EBITDA

N/A

EV/Sales

5.59

Revenue

$931.05M

EBIT

-$499.99M

EBITDA

-$466.15M

Free cash flow

-$387.25M

Per share
Balance sheet
Liquidity

EPS

-$4.82

Free cash flow per share

-$3.41

Book value per share

$5.22

Revenue per share

$8.19

TBVPS

$10.98

Total assets

$1.25B

Total liabilities

$651.75M

Debt

$433.81M

Equity

$596.15M

Working capital

$788.66M

Debt to equity

0.73

Current ratio

3.85

Quick ratio

3.6

Net debt/EBITDA

-0.11

Margins
Efficiency
Dividend

EBITDA margin

-50.1%

Gross margin

42.5%

Net margin

-55%

Operating margin

-54.9%

Return on assets

-41.2%

Return on equity

-88.5%

Return on invested capital

-47.2%

Return on capital employed

-51.5%

Return on sales

-53.7%

Dividend yield

N/A

DPS

N/A

Payout ratio

N/A

How has the Natera stock price performed over time

Intraday

-0.51%

1 week

-11%

1 month

-21.63%

1 year

5.69%

YTD

11.95%

QTD

-7.58%

How have Natera's revenue and profit performed over time

Revenue

$931.05M

Gross profit

$395.97M

Operating income

-$511.55M

Net income

-$511.79M

Gross margin

42.5%

Net margin

-55%

The company's net margin rose by 31% YoY and by 13% QoQ

NTRA's operating margin is up by 30% year-on-year and by 12% since the previous quarter

NTRA's revenue is up by 29% year-on-year and by 7% since the previous quarter

Natera's gross profit has increased by 18% YoY and by 8% QoQ

What is Natera's growth rate over time

What is Natera stock price valuation

P/E

N/A

P/B

8.62

P/S

5.49

EV/EBIT

N/A

EV/EBITDA

N/A

EV/Sales

5.59

The EPS has increased by 21% YoY and by 10% from the previous quarter

The stock's P/B is 69% less than its 5-year quarterly average of 27.8 and 4.7% less than its last 4 quarters average of 9.1

NTRA's equity is up by 34% year-on-year but it is down by 8% since the previous quarter

NTRA's price to sales (P/S) is 44% lower than its 5-year quarterly average of 9.9 and 4.8% lower than its last 4 quarters average of 5.8

NTRA's revenue is up by 29% year-on-year and by 7% since the previous quarter

How efficient is Natera business performance

The ROS has increased by 31% YoY and by 13% from the previous quarter

The ROA is up by 15% year-on-year and by 10% since the previous quarter

The ROE has grown by 12% from the previous quarter and by 8% YoY

The return on invested capital has increased by 4.5% since the previous quarter but it has declined by 4% year-on-year

What is NTRA's dividend

DPS

N/A

Dividend yield

N/A

Payout ratio

N/A

There are no recent dividends present for NTRA.

How did Natera financials performed over time

NTRA's total assets is 91% higher than its total liabilities

NTRA's total assets is up by 17% YoY but it is down by 5% QoQ

The current ratio is up by 8% year-on-year

The company's debt is 27% lower than its equity

NTRA's equity is up by 34% year-on-year but it is down by 8% since the previous quarter

The debt to equity has contracted by 18% YoY but it has grown by 9% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.